Ubs Asset Management Americas Inc 89bio, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in 89bio, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 391,410 shares of ETNB stock, worth $5.82 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
391,410
Previous 268,798
45.61%
Holding current value
$5.82 Million
Previous $1.95 Million
96.67%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ETNB
# of Institutions
214Shares Held
162MCall Options Held
299KPut Options Held
1.61M-
Janus Henderson Group PLC London, X020.8MShares$309 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$296 Million4.27% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.2MShares$211 Million4.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.5MShares$141 Million3.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.24MShares$123 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $692M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...